Seeded at onboarding 2026-07-26, recorded honestly: Kim's starting point is a sector-cycle bet — the company itself is not deeply known, and his picture of it comes from B3's own reporting. The strengths and weaknesses below are evidence-backed observations from the onboarding fact research, to be confirmed, sharpened, or culled as Kim forms his own view.
Format: date — what happened (source) — why it matters. An Effect: line is added when a story triggers a model update (no model exists yet).
- 2025-07-15 — Q2 2025 report: organic revenue −11.2%, adjusted operating margin 4.2%, parent shareholders kept 0.3 of 2.6 MSEK profit (Q2 2025 report).
Why it matters: the first report after the first buys — weak organic growth and minority leakage were already visible in it.
- 2025-10-22 — Q3 2025 report: organic −14.2%, operating margin 1.9%, group loss −3.3 MSEK, utilisation trough 81.7%, net debt 210 MSEK (Q3 2025 report); the same day the board replaced chief executive Martin Stenström with board member Daniel Juhlin, in office from February 2026 (Cision).
Why it matters: the trough quarter, and the board's governance answer to it — the report itself is silent on the change, signed by the outgoing chief executive and published at 9 p.m.
- 2026-02-19 — Year-End Report 2025: full-year organic −12.6%, adjusted operating margin 4.4%, parent kept 10.9 of 14.5 MSEK profit; zero dividend proposed for the second straight year, to "retain cash… strengthen the financial position… future acquisitions" (Year-End Report 2025).
Why it matters: two foundations watch these exact lines (margin recovery, no-distress), and the second zero dividend removed any income case.
- 2026-04-28 — Q1 2026 report: organic −13.1 points; chief-executive letter: 2026 began with a slightly brighter outlook, but "the war in Iran has once again made the market more cautious" (Q1 2026 report).
Why it matters: tests the cyclical-turn foundation — the turn had not come by Q1, and geopolitics is the stated reason.
- 2026-05-13 — Annual general meeting confirmed zero dividend for 2025 (communiqué, MFN).
Why it matters: formalized the second zero year — the income thesis stays dead until a board reverses it.
- 2026-05-29 — Share count rose to 9,478,479 after in-kind share issues paying for the B3 Skilled (95→98%) and B3 HealthTech (70→100%) minority buy-ins (press release).
Why it matters: the minority buy-in foundation in action — the parent's share of profit rises, paid in dilution rather than cash.
- 2026-07-03 — Habberstad (segment B3 Norway) agreed sold back at original cost, ~NOK 15.9 million; extraordinary general meeting 2026-08-19, completion expected August (notice, MFN).
Why it matters: the expansion narrative unwound at cost after 17 months — capital discipline or strategy churn; the next quarters decide which reading holds.
- 2026-07-16 — Q2 2026 report: operating profit up to 12.1 MSEK (from 10.3) on 3% lower revenue; utilisation 86.1%; parent earnings per share −0.07 while the group made +1.9 MSEK; the new 250 MSEK three-year senior secured bond settled the same day (Q2 2026 report).
Why it matters: first hard evidence for the consolidation-delivers foundation — and the clearest print yet of the minority leakage the thesis must overcome.
- 2026-07-16/17 — All three market proxies reported Q2 2026: Knowit revenue −3.8% (−0.9% underlying, excluding acquisitions and divestments), utilisation up a sixth straight quarter, adjusted margin 3.6 → 4.3% (report); CAG Group +11.3% with organic growth +1.7% and adjusted margin 8.3% (report); Softronic +11.9% to 256 MSEK with operating profit before amortisation 25.4 MSEK from 19.4 (report). B3's own quarter was −3.4%, first-half organic −7.5% excluding Habberstad. All three name the same demand pockets: defence, cybersecurity, AI.
Why it matters: the first outside-in evidence that the Swedish downturn is cyclical and turning — the peers convert the turn into volume, B3 into utilisation of a shrinking co-worker base. This is the first of the two consecutive quarters that would make "the market turns, B3 stands still" a thesis wound; the third quarter of 2026 decides.
- 2026-08-19 — Extraordinary general meeting approved selling all of B3's 51% of Habberstad to HAS Gruppen AS — the buyers are Habberstad's own management and staff, so Swedish insider-transaction law required the meeting's blessing at a nine-tenths majority, which it gave. Every condition for completion is now met; completion is expected during August (communiqué, MFN).
Why it matters: the Norway unwind turns from conditional to certain, and the board finally sized it — Habberstad is about 8% of group revenue, so reported revenue steps down from the third quarter for a reason that has nothing to do with the market cycle. The organic growth line strips divestments and stays the comparable one, which is where the peer inflection is read. B3 keeps a foot in Norway through its stake in Habberstad Rekruttering og Utvikling and continuing client work; the at-cost price was judged fair on this year's results, an updated business plan and an internal valuation, and the board expects no material effect on earnings or financial position.